MRC1 and sarcoma: Additionally, in a recent study involving 1162 patients with sarcoma who were unselected with regard to family history of cancer, 20% of patients had pathogenic (P) or likely pathogenic (LP) variants in 72 genes associated with the increased risk of cancer, including 11 patients with P or LP variants in MMR genes [10].